Conduct study 222
Active Awarded Last action
- Contract number
- 75N93024F00002
- Awardee
-
The Administrators Of Tulane Educational Fund UEI XNY5ULPU8EN6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,722,748
Award facts
- Contract value 100% obligated
- $1,722,748.00 Current and potential, with all options
- Completion date 82% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- New Orleans, LA 70118, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,722,748 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $1.72 million to The Administrators of Tulane Educational Fund, doing business as Tulane University, on September 13, 2024, for Conduct Study 222 under the Simian Vaccine Evaluation Units program. This cost-plus-no-fee delivery order is scheduled for completion by April 11, 2027, with work to be performed in New Orleans, Louisiana. The award carries no set-aside designation, reflecting Tulane's competitive capabilities in this specialized research domain. This delivery order is issued under the parent contract vehicle for Simian Vaccine Evaluation Units, leveraging Tulane's extensive infrastructure and expertise in vaccine development and evaluation research.
Tulane University, home to the Tulane National Primate Research Center—one of seven NIH-funded National Primate Research Centers—brings substantial expertise to vaccine evaluation and infectious disease research. The institution has established a strong track record with NIAID, including prior awards of $22.6 million for operation of the Cellular Immunology Core Laboratory and substantial funding under a $146.3 million indefinite delivery contract for preclinical infectious disease models. This delivery order supports NIAID's mission to conduct critical vaccine evaluation studies, building on Tulane's demonstrated capabilities in biomedical research infrastructure, specialized scientific services, and collaborative research networks that position the institution as a key federal research partner.
Quick answers
Who was awarded contract 75N93024F00002?
75N93024F00002 was awarded to The Administrators Of Tulane Educational Fund by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 13, 2024.
How much is contract 75N93024F00002 worth?
The government has obligated $1,722,748 on 75N93024F00002.
Is contract 75N93024F00002 an order under another contract?
Yes. 75N93024F00002 is a delivery order under 75N93020D00007, an indefinite delivery contract, on Simian Vaccine Evaluation Units.
Was contract 75N93024F00002 competed?
The extent of competition for 75N93024F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award